๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Selectivity of the micro-leukocyte adherence inhibition assay in pancreatic cancer

โœ Scribed by H. O. Douglass Jr.; A. J. Russo; J. H. Howell; M. C. Moore; S. G. Arbuck; T. M. Chu; M. H. Goldrosen

Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
437 KB
Volume
43
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Capillary tube leukocyte adherence inhib
Capillary tube leukocyte adherence inhibition: An assay for cell-mediated immunity in cancer patients
โœ Marshall M. Urist; Arthur W. Boddie Jr.; E. Carmack Holmes; Donald L. Morton ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 328 KB

## Abstract The leukocyte adherence inhibition (LAI) assay has been modified and automated in order to facilitate its clinical application. This new assayโ€the capillary tube LAI testโ€correlated with delayed cutaneous hypersensitivity using streptokinaseโ€streptodornase antigen in 83% of the cases. W

The use of cryopreserved lymphocytes in
The use of cryopreserved lymphocytes in the leukocyte adherence inhibition assay. I. Evaluation of specificity of responses in cancer patients
โœ Stephen R. Waldman; Robert H. Yonemoto ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 887 KB

## Abstract Frozenโ€stored mononuclear cells were utilized in the leukocyte adherence inhibition (LAI) assay in studies which were designed to determine (1) the optimal concentration of breast adenocarcinoma and colon adenocarcinoma extracts, (2) the specificity of frozenโ€stored cell responses to th

A modified leukocyte adherence inhibitio
A modified leukocyte adherence inhibition test in the laboratory investigation of gastrointestinal cancer
โœ J. C. Rutherford; B. A. J. Walters; G. Cavaye; W. J. Halliday ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 531 KB

## Abstract A modification of the leukocyte adherence inhibition (LAI) technique has been used to test 60 hospital patients with gastrointestinal symptoms, for specific immunoreactivity against extracts of tumours of colon, pancreas and stomach. The modified technique employed mononuclear cells and